Board Of Directors Vanguard Health System News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Published: Dec 07, 2020
 
NEWTON, Mass., Dec. 7, 2020 /PRNewswire/  Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel, enzyme-based products, today announced the appointment of Alan Muney, MD to its Board of Directors. Dr. Muney is currently a senior healthcare advisor for Pritzker Private Capital, Arsenal Capital, Bain Management Consulting, and NEA Venture Capital.
I feel privileged to be involved with such a talented team dedicated to the mission of bringing a great technology to market to help chronically ill patients, said Dr. Muney.
Previously Dr. Muney served as Cigna s Chief Medical Officer and Executive Vice President of Total Health and Network. In his role as Chief Medical Officer, Dr. Muney was responsible for Cigna s clinical strategy and policy, health advocacy programs, coverage policy, and quality measurement and improvement. As lead for Total Health and Network, Dr. Muney was r ....

United States , Dan Orlando , Alan Muney , Daniel Orlando , Alcresta Therapeutics Inc , Board Of Directors Vanguard Health System , University Of La Verne , Oxford Health , Healthquest Capital , Equity Group , Masters In Health Administration , Team Health , Blackstone Group , Brown University , Alcresta Therapeutics , Pritzker Private Capital , Arsenal Capital , Bain Management Consulting , Chief Medical Officer , Executive Vice President , Total Health , Executive Director , Private Equity Group , Equity Healthcare , Vanguard Health System , Oxford Health Plans ,